Table 1.
Patients’ clinical characteristics.
| Characteristic | NV (n = 11) | VAC (n = 9) |
|---|---|---|
| Mean age (years) | 54.5 | 49.1 |
| TNM | ||
| 1 | 2 | 1 |
| 2 | 8 | 7 |
| 3 | 1 | 1 |
| Clinical stage | ||
| II | 4 | 3 |
| III | 8 | 6 |
| Clinical lymph node classification | ||
| N0 | 2 | 2 |
| N1 | 6 | 5 |
| N2 | 3 | 2 |
| N3 | 0 | 0 |
| Systemic metastases | ||
| No | 11 | 9 |
| Yes | 0 | 0 |
| Estrogen receptor (ER) | ||
| Positive (>10%) | 7 | 5 |
| Negative (<10%) | 4 | 4 |
| Progesterone receptor (PR) | ||
| Positive (>10%) | 7 | 5 |
| Negative (<10%) | 4 | 4 |
| Ki-67 (%) | 42 | 37 |
| Her2/neu | ||
| Positive | 3 | 2 |
| Negative | 8 | 7 |
| Breast cancer subtypes | ||
| Luminal A | 2 | 1 |
| Luminal B | 8 | 6 |
| Basal like | 0 | 1 |
| Her2/neu overexpressing | 1 | 1 |